Home › Funds › Omega Fund Management, LLC › KMTS

Omega Fund Management, LLC position in KMTS

KESTRA MEDICAL TECHNOLOGIES · Health Care

Omega Fund Management, LLC reported holding 1,022,149 shares of KMTS (KESTRA MEDICAL TECHNOLOGIES) in its Q2 2026 13F filing — a position valued at US$26.0M, representing 14.00% of its reported portfolio and ranking #3 among its reported holdings. Omega Fund Management, LLC has disclosed KMTS holdings in 6 of the last 6 reported quarters, going back to Q1 2025.

Latest position (Q2 2026)1.02M sh
Reported value held$26.00M
Portfolio Weight14.00%
First reportedQ1 2025
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Omega Fund Management, LLC's KMTS position evolved

Omega Fund Management, LLC first disclosed a stake in KMTS in Q1 2025 at 1,795,893 shares (US$44.8M). Across 6 filings, Omega Fund Management, LLC increased the stake 0 time(s), trimmed it 3 time(s) and left it unchanged 2 time(s). The most recent filing (Q2 2026) shows 1,022,149 shares valued at US$26.0M. Notable position changes include a 26% trim in Q1 2026 (shares rose 28% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2025 1.80M $44.75M New
Q2 2025 1.65M $27.29M Reduce
Q3 2025 1.65M $39.11M Hold
Q4 2025 1.37M $36.43M Reduce
Q1 2026 1.02M $20.37M Reduce
Q2 2026 1.02M $26.00M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About KMTS and 13F data

KMTS (KESTRA MEDICAL TECHNOLOGIES) is a Health Care company. 70 other funds we track also report a position in KMTS — the largest reported positions include BAIN CAPITAL INVESTORS LLC (US$640.4M), Andera Partners (US$77.2M), Yu Fan (US$58.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding KMTS

All KMTS fund holders →

FAQ

How long has Omega Fund Management, LLC held KMTS?

Omega Fund Management, LLC has disclosed KMTS holdings in 6 of the last 6 reported quarters, going back to Q1 2025.

What is Omega Fund Management, LLC's current position in KMTS?

As of Q2 2026, Omega Fund Management, LLC holds 1.02M shares of KMTS (KESTRA MEDICAL TECHNOLOGIES), valued at $26.00M, representing 14.00% of its reported portfolio and ranking #3.

Has Omega Fund Management, LLC been buying or selling KMTS?

In the latest 13F filing (Q2 2026), Omega Fund Management, LLC held unchanged its position in KMTS.

Which other funds hold KMTS?

Other major institutional holders of KMTS include BAIN CAPITAL INVESTORS LLC, Andera Partners, Yu Fan, among 70 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.